Skip to content

SOFIPHAR

Inactive KBO/BCE: BE 0402.008.679 subsidiary of Ralypharm

Curator

1 mandate
Curator, Rue Du Long Thier 2, 4500 Huy
from 27-06-2022 to 16-05-2023
Also on 43 other cases

Last board

1 director, 1 in day-to-day management, last change in 2021
VAN DE VELDE Françoise
Manager
in office according to the deed of 12-03-2021
Manager
in office according to the deed of 12-03-2021
RALYPHARM

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
VAN DE VELDE Françoise
Manager
RALYPHARM
Manager
LeadershipBoardmandate already running before its first mentionBankruptcy 27-06-2022
Mandates as a list
  • VAN DE VELDE Françoise
    • Manager, from before 12-03-2021, until the bankruptcy of 27-06-2022
  • RALYPHARM
    • Manager, from before 12-03-2021, until the bankruptcy of 27-06-2022

Control

Consolidating parent
consolidates
This company
SOFIPHAR
Equity €87,210
Profit €5,191 in 2019

Capital

Capital
€18,600
Source
2019 annual accounts

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Next steps